STOCK TITAN

UNITEDHEALTH GROUP INC (UNH) SEC Filings, Mar-Apr 2026

UNH NYSE

Welcome to our dedicated page for UNITEDHEALTH GROUP SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNITEDHEALTH GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNITEDHEALTH GROUP's regulatory disclosures and financial reporting.

Rhea-AI Summary

Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Scott Gottlieb received a grant of 320 deferred stock units of Common Stock as regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 446 shares/units in total.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Valerie Montgomery Rice, MD, received an award of 343 deferred stock units of common stock as regular quarterly compensation for Board service. The units are immediately vested but must be held until she completes her Board service. Following this grant, she directly holds 7,615 shares/units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.

UnitedHealth Group director Timothy Patrick Flynn received a grant of 350 shares of Common Stock-equivalent deferred stock units on April 1 as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board.

Following this grant, Flynn directly holds 10,589 shares of UnitedHealth Group common stock. In addition, an indirect holding entry reflects 6,033 shares held by a trust, indicating a separate ownership structure for part of his overall position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UnitedHealth Group Inc ownership disclosure: The Vanguard Group filed Amendment No. 11 to its Schedule 13G/A reporting that it beneficially owns 0 shares of Common Stock, representing 0%. The filing states this result follows an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 (January 12, 1998), and that certain Vanguard subsidiaries now report holdings separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

UNITEDHEALTH GROUP INC director Valerie Montgomery Rice received 53 shares of Common Stock as a grant. The Form 4 shows this as a compensation-related acquisition, with no purchase price. The footnote explains these are dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this grant, her directly held Common Stock totals 7,272 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported an automatic stock-based award rather than a market trade. He acquired 149.989 shares of common stock at a stated price of $0.0000 per share, increasing his direct holdings to 19,666.93 shares.

According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine compensation-related accrual rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz reported an acquisition of common stock tied to existing equity awards. On March 17, 2026, he received 68.058 shares of common stock at no cost as dividend equivalents on outstanding restricted stock units, which are subject to the same vesting conditions and are forfeited if the underlying units do not vest. Following this award, his directly held common stock position increased to 10,205.939 shares, indicating a routine compensation-related update rather than an open-market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UnitedHealth Group director Paul R. Garcia received an equity-based award linked to existing deferred stock units. On March 17, 2026, he acquired 16 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units that are immediately vested and subject to the same terms as the underlying units.

Following this grant, Garcia directly holds 3,330 shares of UnitedHealth Group common stock. He also has indirect holdings reported through a revocable trust and additional trusts, reflecting shares held in estate-planning vehicles rather than through open‑market transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UNITEDHEALTH GROUP INC director John H. Noseworthy received 52 shares of common stock as a grant tied to dividend equivalents on vested deferred stock units. The shares were acquired at no cost, are immediately vested, and follow the same terms as the underlying deferred stock units. After this award, he directly holds 7,049 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards. On March 17, 2026, he acquired 89.629 shares of Common Stock at a stated price of $0.00 per share, reported as a grant or award acquisition.

The footnote explains this represents dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. After this transaction, Zaetta directly holds 16,716.169 shares of Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many UNITEDHEALTH GROUP (UNH) SEC filings are available on StockTitan?

StockTitan tracks 184 SEC filings for UNITEDHEALTH GROUP (UNH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UNITEDHEALTH GROUP (UNH)?

The most recent SEC filing for UNITEDHEALTH GROUP (UNH) was filed on April 6, 2026.